CLB — Core Laboratories Cashflow Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMid CapNeutral

Annual cashflow statement for Core Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-97.1	20.2	19.7	37	32.2
Depreciation
Deferred Taxes
Non-Cash Items	140	12.4	12.7	11.6	0.729
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	5.94	-20.6	-25	-28.8	7.88
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	57.9	36.6	25	24.8	56.4
Capital Expenditures	-11.9	-13.5	-10.2	-10.6	-13
Purchase of Fixed Assets
Other Investing Cash Flow Items	19.7	3.32	6.36	3.93	6.63
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	7.85	-10.2	-3.86	-6.65	-6.39
Financing Cash Flow Items	-1.77	-1.37	-2.62	-5.38	-0.775
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-63	-22.5	-23.4	-18.4	-46
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2.71	3.9	-2.27	-0.308	4.04